Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 23599514)

1.

Buprenorphine-induced respiratory depression and involvement of ABCB1 SNPs in opioid-induced respiratory depression in paediatrics.

Niesters M, Overdyk F, Smith T, Aarts L, Dahan A.

Br J Anaesth. 2013 May;110(5):842-3. doi: 10.1093/bja/aet084. No abstract available.

2.

P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example.

Mégarbane B, Alhaddad H.

Br J Anaesth. 2013 May;110(5):842. doi: 10.1093/bja/aet082. No abstract available.

3.

Opioid-induced respiratory effects: new data on buprenorphine.

Dahan A.

Palliat Med. 2006;20 Suppl 1:s3-8.

PMID:
16764215
4.

Opioid-induced respiratory depression in paediatrics: a review of case reports.

Niesters M, Overdyk F, Smith T, Aarts L, Dahan A.

Br J Anaesth. 2013 Feb;110(2):175-82. doi: 10.1093/bja/aes447. Epub 2012 Dec 17. Review.

5.

Reply from the authors.

Dahan A.

Br J Anaesth. 2013 May;110(5):844-5. doi: 10.1093/bja/aet086. No abstract available.

6.

Codeine: the 'safe' analgesic?

Wynn-Jones W, Casely E, Laycock H, Bantel C.

Br J Anaesth. 2013 May;110(5):843-4. doi: 10.1093/bja/aet085. No abstract available.

7.

Risk factors for opioid-induced excessive respiratory depression.

Jungquist CR, Karan S, Perlis ML.

Pain Manag Nurs. 2011 Sep;12(3):180-7. doi: 10.1016/j.pmn.2010.02.001. Epub 2010 Jul 24. Review.

PMID:
21893307
8.

Antihistamines and potentiation of opioid induced sedation and respiratory depression.

Anwari JS, Iqbal S.

Anaesthesia. 2003 May;58(5):494-5. No abstract available.

PMID:
12694022
9.

Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy.

Moro C, Taino R, Mandalà M, Labianca R.

Ann Oncol. 2006 Sep;17(9):1466-7. Epub 2006 Apr 26. No abstract available.

10.

The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression.

Benedetti F, Amanzio M, Baldi S, Casadio C, Cavallo A, Mancuso M, Ruffini E, Oliaro A, Maggi G.

Pain. 1998 Apr;75(2-3):313-9.

PMID:
9583767
11.
12.

Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.

Br J Anaesth. 2006 May;96(5):627-32. Epub 2006 Mar 17.

13.

Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids?

Clemens KE, Quednau I, Klaschik E.

J Palliat Med. 2008 Mar;11(2):204-16. doi: 10.1089/jpm.2007.0131.

PMID:
18333735
14.

All parturients receiving neuraxial morphine should be monitored with continuous pulse oximetry.

D'Angelo R.

Int J Obstet Anesth. 2010 Apr;19(2):202-4. doi: 10.1016/j.ijoa.2009.08.001. Epub 2010 Mar 3. No abstract available.

PMID:
20202817
15.

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.

Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.

Br J Anaesth. 2005 Jun;94(6):825-34. Epub 2005 Apr 15.

16.

Avoiding opioid-induced respiratory depression.

Pasero CL, McCaffery M.

Am J Nurs. 1994 Apr;94(4):24-30; quiz 30-1. No abstract available.

PMID:
7908500
17.

Non-analgesic effects of opioids: opioid-induced respiratory depression.

Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A.

Curr Pharm Des. 2012;18(37):5994-6004. Review.

PMID:
22747535
18.

Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences.

Mégarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ.

Toxicol Rev. 2006;25(2):79-85. Review.

PMID:
16958555
19.

All parturients receiving neuraxial morphine should be monitored with continuous pulse oximetry.

Smiley R.

Int J Obstet Anesth. 2010 Apr;19(2):204-8. doi: 10.1016/j.ijoa.2009.08.002. Epub 2010 Mar 3. No abstract available.

PMID:
20202820
20.

Pharmacological strategy for overcoming opioid-induced ventilatory disturbances.

Kimura S, Haji A.

Eur J Pharmacol. 2014 Feb 15;725:87-90. doi: 10.1016/j.ejphar.2013.08.007. Epub 2013 Aug 28. Review.

PMID:
23993949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk